Calidi Biotherapeutics, Inc. (CLDI)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.70
- As of
Kresmion compiles this page from CLDI's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Calidi Biotherapeutics, Inc. (CLDI): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-25.
See the full CLDI dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CLDI on one page. Preview it with sample data, then open it live with a free account.
Preview the CLDI dossierActive events for CLDI
- mediumEarnings below estimates
Q1-2025: Missed consensus by 19.2% - EPS $-2.16 vs $-1.8115 estimate
- mediumEarnings below estimates
Q3-2025: Missed consensus by 29.0% - EPS $-2.21 vs $-1.7136 estimate
- mediumEarnings above estimates
Q4-2025: Beat consensus by 73.6% - EPS $-0.43 vs $-1.6279 estimate
FREE, NO ACCOUNT
Every event on CLDI, as it fires
New filings, 13F moves and cross asset events on CLDI land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter.
Recent SEC filings, CLDI
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
CLDI's 10-Q filed Aug 13, 2026 states:
The Company estimates that based on the Company's liquidity resources, there is substantial doubt about the Company's ability to continue as a going concern within 12 months from the date of issuance of these unaudited condensed consolidated financial statements.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on CLDI
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in CLDI on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on CLDI in the last 180 days.
Upstream: SEC EDGAR filings for CLDI
Kresmion, "Calidi Biotherapeutics, Inc. (CLDI) institutional holdings and SEC filings", data as of 2026-09-25, https://kresmion.com/research/CLDI. Upstream data: SEC EDGAR filings for CLDI.
Link to this data (HTML):
<a href="https://kresmion.com/research/CLDI">Calidi Biotherapeutics, Inc. (CLDI) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow CLDI on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to CLDI for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.